Prof. Dr. Antonia Joussen, Ophthalmologist in Berlin, Germany - Appointment

About Prof. Dr. Antonia Joussen

Prof. Dr. Antonia Joussen is a respected Ophthalmologist with 18+ years of experience.
She completed her study in medicine at the Ruhr University Bochum and at Heidelberg University, Germany in 1990 and started working as a Research Fellow at Children's Hospital & Massachusetts Eye and Ear Infirmary, Harvard Medical School, Boston, the USA in 1999.
She has won several awards such as a Doctoral thesis award from the German Ophthalmological Society, sponsored by the Wacker Fund, 1997, and lastly Undergraduate scholarship from the Cusanuswerk 1991 - 1996.
In 2000, she was appointed as an instructor at Massachusetts Eye and Ear, Harvard Medical School.
After returning to Germany, she received the Emmy Noether Career Development Grant (Scientific Excellence Program) from the German Research Foundation from 2002 to 2007.
Dr. Joussen's areas of interest under the subject include Paediatric Ophthalmology, Squint, Retinopathy of prematurity, Glaucoma, Eye trauma, General Ophthalmology, etc.
She has been the Editor in Chief of "Graefes Archives of Ophthalmology" and has several articles and chapters under her name in national and international journals.

Charite University Hospital

Berlin, Germany

Joussen, A.M. et al.: Leukocyte mediated cell injury and death in the diabetic retina. In: Am J Pathol. 158, 2001. S. 147-152.

+ Read More

Joussen, A.M. et al.: In vivo retinal gene expression in early diabetes. In: Invest Ophthalmol Vis Sci 42, 2001. S. 3047-3057.
Joussen, A.M. et al.: Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. In: Am J Pathol 160, 2002. S. 501-509.
Joussen, A.M. et al.: Suppression of diabetic retinopathy with Angiopoietin-1. In: Am J Pathol 160, 2002. S. 1683-1693.
Joussen, A.M. et al.: Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-a suppression. In: FASEB J 16, 2002. S. 438-440.
Joussen, A.M. et al.: Suppression of Fas-FasL induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. In: FASEB J 17, 2003. S. 76-78.
Poulaki, V. et al.: Activin A in the regulation of corneal neovascularization and VEGF expression. In: Am J Pathol 164, 2004. S. 1293-1302.
Poulaki, V. et al.: Insulin-like growth factor-I plays a pathogenetic role in diabetic retinopathy. In: Am J Pathol. 165(2), 2004. S. 457-469.
Joussen, A.M. et al.: A central role for inflammation in the pathogenesis of diabetic retinopathy. In: FASEB J. 18(12), 2004. S. 1450-1452.
Semkova, I. et al.: Overexpression of FasL in retinal pigment epithelial cells reduces choroidal neovascularization. In: FASEB J. 20(10), 2006. S. 1689-1691.

Prof. Dr. Antonia Joussen practices at Charite University Hospital

Prof. Dr. Antonia Joussen specialty is Glaucoma Specialist

Prof. Dr. Antonia Joussen is Glaucoma Specialist with 22 years of experience.